CDK inhibitor SB1317, Purity ≥98%

Cat. No.: X23-10-ZQ417

CDK inhibitor SB1317, Purity ≥98%

Synonym: SB1317; Zotiraciclib; 1204918-72-8; TG-02; 937270-47-8; SB-1317; TG02; CDK inhibitor

  • MDL: MFCD22124499
  • CAS Number: 1204918-72-8
  • Compound CID: 16739650
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SB1317 is an CDK kinase inhibitor that disrupts cell division processes.
Molecular Weight
372.46
Molecular Formula
C23H24N4O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SB1317 can be employed to study the PI3K/AKT/mTOR pathway along with JAK signaling inhibition.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.